| Patient | John F. Kennedy |
|---|---|
| Date of birth | 1995-05-29 |
| Identifiers | MRN HR-ML023-SYN; SSN (made up) 000-23-5408 |
| Document date | 2026-10-19 |
| Author | Harlan Prescott, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Nine-month review: replacement, thyroid, autoimmune screening, bone health, and back pain. [S]
Mr. Kennedy returns nine months after his first visit. He feels well and works full days. He takes hydrocortisone 10, 5 and 5 mg, fludrocortisone 0.1 mg and levothyroxine 50 mcg without missed doses. He has had no illness needing stress doses since the influenza in the winter, and he carries his kit and wears his medical ID. He has no salt craving, lightheadedness, palpitations or cold intolerance. His back is stiff after long flights but no longer limits him, and he swims most days. His mood is good. [S]
| Element | Detail |
|---|---|
| Replacement | Hydrocortisone 20 mg a day in three doses; fludrocortisone 0.1 mg; levothyroxine 50 mcg |
| Illness | None since the winter; no crisis |
| Back | Stiff after long flights only; Oswestry 14% |
| Mood | Good; PHQ-9 2 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good; weight stable |
| Cardiovascular | Negative | No lightheadedness, palpitations, or ankle swelling |
| Gastrointestinal | Negative | No salt craving, abdominal pain, or diarrhea |
| Endocrine | Negative | No cold or heat intolerance, tremor, or thirst |
| Musculoskeletal | Positive | Back stiffness after long flights |
| Psychiatric | Negative | Mood good |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrocortisone 10 mg oral tablet, two tablets (20 mg) on waking and one tablet (10 mg) at 2 pm, 30 mg a day (started in hospital) | Two tablets on waking and one tablet at 2 pm | Oral route | 2025-10-06 to 2026-01-26 | completed | S |
| Fludrocortisone 0.1 mg oral tablet, half a tablet (0.05 mg) by mouth once daily (started in hospital) | Half a tablet by mouth once daily | Oral route | 2025-10-06 to 2026-01-26 | completed | S |
| Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking | One tablet by mouth on waking | Oral route | 2026-01-26 | active | S |
| Hydrocortisone 5 mg oral tablet, one tablet by mouth at noon and one at 4 pm | One tablet at noon and one tablet at 4 pm (two doses a day) | Oral route | 2026-01-26 | active | S |
| Fludrocortisone 0.1 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily | Oral route | 2026-01-26 | active | S |
| Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 | Once, as needed for adrenal crisis; carry at all times | Intramuscular route | 2026-01-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times a day as needed for back pain | Two tablets up to three times a day as needed | Oral route | 2026-01-12 | active | S |
| Oseltamivir 75 mg oral capsule, one capsule by mouth twice daily for five days | One capsule twice daily for five days | Oral route | 2026-02-16 to 2026-02-20 | completed | S |
| Levothyroxine 50 mcg oral tablet, one tablet by mouth each morning on an empty stomach | One tablet each morning, 30 to 60 minutes before breakfast | Oral route | 2026-03-09 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-19 | Body height | 183 | cm | S |
| 2026-10-19 | Body weight | 72 | kg | S |
| 2026-10-19 | Body mass index (BMI) [Ratio] | 21.5 | kg/m2 | S |
| 2026-10-19 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-10-19 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-19 | Heart rate | 70 | /min | S |
| 2026-10-19 | Respiratory rate | 14 | /min | S |
| 2026-10-19 | Body temperature | 36.6 | Cel | S |
| 2026-10-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-19 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-10-19 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-10-19 | Creatinine [Mass/volume] in Serum or Plasma | 0.95 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-10-19 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 110 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-10-19 | Renin [Enzymatic activity/volume] in Plasma | 2.2 | ng/mL/h | Upright, mid-morning: 0.6 to 4.3 ng/mL/h | Normal | S |
| 2026-10-19 | Thyrotropin [Units/volume] in Serum or Plasma | 2 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-10-19 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 2026-10-19 | Oswestry disability index score ODI | 14 | {score} | S |
Vital signs recorded on 2026-10-19; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 72.0 kg, BMI 21.5 |
| Blood pressure lying and standing | 120/76 lying, pulse 68; 118/74 after three minutes standing, pulse 72: no postural drop |
| Skin | Pigmentation faded; no thin skin, striae, or bruising |
| Neck | Thyroid not enlarged |
| Extremities | No edema |
| Back | Full forward flexion; no tenderness; neurological examination of the legs normal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Primary adrenal insufficiency (Addison's disease), diagnosed about three months ago during an adrenal crisis while traveling abroad, on hydrocortisone and fludrocortisone; synthetic modern episode linked to his documented 1947 diagnosis | active | confirmed | E27.1 | S — Synthetic modern coding of the documented diagnosis. |
| Chronic low back pain persisting after lumbar disc surgery; began after a football injury in college and worsened during wartime naval service; uses a corset brace; synthetic modern episode linked to his documented back history | active | confirmed | M96.1 | S — Synthetic modern coding of the documented back pain and operation. |
| Raised TSH with positive thyroid peroxidase antibodies and normal free T4 on screening for associated autoimmune disease; to be repeated before any treatment | resolved | confirmed | R94.6 | S — Synthetic screening finding. |
| Autoimmune (Hashimoto's) hypothyroidism, part of an autoimmune polyglandular syndrome with the adrenal insufficiency; started on levothyroxine | active | confirmed | E06.3 | S — Synthetic modern diagnosis anchored to his documented later hypothyroidism and its retrospective interpretation. |
| Influenza A with fever, managed at home with oseltamivir and doubled hydrocortisone under the sick-day rules; resolved | resolved | confirmed | J10.1 | S — Synthetic intercurrent illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Glucocorticoid dose: weight, energy, and signs of under- or over-replacement | Every visit | Completed today | Weight 72.0 kg, his usual; energy good; no signs of excess |
| Examination | Blood pressure lying and standing | Every visit | Completed today | 120/76 lying, 118/74 standing: no postural drop |
| Laboratory | Mineralocorticoid: salt craving, edema, sodium and potassium | After any fludrocortisone change, then at least yearly | Completed today | Sodium 139, potassium 4.3 mmol/L, creatinine 0.95 mg/dL, eGFR 110 |
| Laboratory | Plasma renin activity | After any fludrocortisone change, then at least yearly; aim for the upper normal range | Completed today | 2.2 ng/mL/h, normal |
| Self-management | Sick-day rules, emergency injection kit, steroid card, and medical ID | Every visit | Completed today | Kit in date; card and medical ID with him; travel supplies checked |
| Laboratory | TSH and free T4 | 4 to 8 weeks after starting or changing levothyroxine, at 6 months once stable, then yearly | Completed today | TSH 2.0 mIU/L at six months once stable; next yearly |
| Medication safety | Levothyroxine: timing, interactions, and signs of over-replacement | At each thyroid review | Completed today | Taken correctly; no signs of over-replacement |
| Laboratory | Other associated autoimmune disease: vitamin B12, A1c, and celiac serology | At diagnosis, then yearly or with symptoms | Due | Normal at intake; due at one year, in three months |
| Imaging | Bone density (DXA) | Once; repeat only if risk rises | Not indicated | Z-scores within the expected range; replacement dose physiological; no fracture. No repeat scan planned |
| Survey | Depression screen | Yearly and when symptoms suggest | Completed today | PHQ-9 2 |
| Survey | Oswestry Disability Index | Each back pain review | Completed today | 14%, from 32% at intake |
| Self-management | Exercise therapy, physical therapy, and brace use | Home program | Completed today | Swims most days; home program; brace for long journeys only |
| Medication safety | Analgesic use | Every visit | Completed today | Acetaminophen rarely |
| Self-management | Hepatitis B vaccine | Two doses at least four weeks apart | Completed today | Dose 2 given today; series complete |
| Self-management | Influenza vaccine | Every autumn | Completed today | Given today |
| Referral | Endocrinology review | At least yearly | Due | Yearly review with Dr. Desai booked in three months |
Goal progress:
Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2; Influenza vaccine, inactivated, this season [S]
Guideline basis: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016); Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (2022); Osteoporosis in men: an Endocrine Society clinical practice guideline (2012); American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023); CMID: Clinical Monitoring Intelligence Database, hypothyroidism monograph (2026); Depression and Suicide Risk in Adults: Screening (2023); Adult Immunization Schedule by Age (2026)
Follow-up: Endocrinology review in three months, with vitamin B12, A1c and celiac serology at one year. Primary care review every six months, with electrolytes and renin yearly and TSH yearly. Follow the sick-day rules for any illness. [S]